• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过无定形固体分散体系统提升植物提取物的物理化学性质及治疗潜力

Advancing the Physicochemical Properties and Therapeutic Potential of Plant Extracts Through Amorphous Solid Dispersion Systems.

作者信息

Budiman Arif, Hafidz Nur Parida Mahdhani, Azzahra Raden Siti Salma, Amaliah Salma, Sitinjak Feggy Yustika, Rusdin Agus, Subra Laila, Aulifa Diah Lia

机构信息

Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang Km. 21, Bandung 45363, Indonesia.

Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang Km. 21, Bandung 45363, Indonesia.

出版信息

Polymers (Basel). 2024 Dec 14;16(24):3489. doi: 10.3390/polym16243489.

DOI:10.3390/polym16243489
PMID:39771340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11679451/
Abstract

Plant extracts demonstrate significant potential as a rich source of active pharmaceutical ingredients, exhibiting diverse biological activities and minimal toxicity. However, the low aqueous solubility of extracts and their gastrointestinal permeability, as well as their poor oral bioavailability, limit clinical advancements due to drug delivery problems. An amorphous solid dispersion (ASD) delivers drugs by changing an active pharmaceutical ingredient (API) into an amorphous state to increase the solubility and availability of the API to the body. This research aimed to analyze and summarize the successful advancements of ASD systems derived from plant extracts, emphasizing characterization and the effects on dissolution and pharmacological activity. The results show that ASD systems improve phytoconstituent dissolution, bioavailability, and stability, in addition to reducing dose and toxicity. This research demonstrates the significance of ASD in therapeutic formulations to augment the pharmacological activities and efficacy of medicinal plant extracts. The prospects indicate promising potential for therapeutic applications utilizing ASD systems, alongside medicinal plant extracts for clinical therapy.

摘要

植物提取物作为丰富的活性药物成分来源显示出巨大潜力,具有多种生物活性且毒性极小。然而,提取物的低水溶性及其胃肠道渗透性,以及较差的口服生物利用度,由于药物递送问题限制了临床进展。无定形固体分散体(ASD)通过将活性药物成分(API)转变为无定形状态来递送药物,以增加API在体内的溶解度和可用性。本研究旨在分析和总结源自植物提取物的ASD系统的成功进展,重点关注表征以及对溶解和药理活性的影响。结果表明,ASD系统除了降低剂量和毒性外,还能改善植物成分的溶解、生物利用度和稳定性。本研究证明了ASD在治疗制剂中增强药用植物提取物的药理活性和功效的重要性。前景表明,利用ASD系统以及药用植物提取物进行临床治疗具有广阔的治疗应用潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8a9/11679451/166c683b5848/polymers-16-03489-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8a9/11679451/0859c6ca719a/polymers-16-03489-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8a9/11679451/166c683b5848/polymers-16-03489-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8a9/11679451/0859c6ca719a/polymers-16-03489-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8a9/11679451/166c683b5848/polymers-16-03489-g002.jpg

相似文献

1
Advancing the Physicochemical Properties and Therapeutic Potential of Plant Extracts Through Amorphous Solid Dispersion Systems.通过无定形固体分散体系统提升植物提取物的物理化学性质及治疗潜力
Polymers (Basel). 2024 Dec 14;16(24):3489. doi: 10.3390/polym16243489.
2
Amorphous Solid Dispersions of Glycyrrhetinic Acid: Using Soluplus, PVP, and PVPVA as the Polymer Matrix to Enhance Solubility, Bioavailability, and Stability.甘草次酸的无定形固体分散体:使用聚乙烯己内酰胺-聚乙酸乙烯酯-聚乙二醇接枝共聚物(Soluplus)、聚乙烯吡咯烷酮(PVP)和聚乙烯吡咯烷酮-醋酸乙烯酯共聚物(PVPVA)作为聚合物基质来提高溶解度、生物利用度和稳定性。
AAPS PharmSciTech. 2024 Dec 21;26(1):18. doi: 10.1208/s12249-024-03007-1.
3
Improved solubility, dissolution rate, and oral bioavailability of main biflavonoids from extract by amorphous solid dispersion.采用无定形固体分散体提高 提取物中主要联苯二氢黄酮的溶解度、溶出速率和口服生物利用度。
Drug Deliv. 2020 Dec;27(1):309-322. doi: 10.1080/10717544.2020.1716876.
4
Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology.利用无定形固体分散技术解决研发阶段的药物制剂问题。
Recent Adv Drug Deliv Formul. 2024;18(2):79-99. doi: 10.2174/0126673878271641231201065151.
5
Mechanistic Insights into Amorphous Solid Dispersions: Bridging Theory and Practice in Drug Delivery.非晶态固体分散体的作用机制见解:药物递送中理论与实践的桥梁
Pharm Res. 2025 Jan;42(1):1-23. doi: 10.1007/s11095-024-03808-w. Epub 2025 Jan 23.
6
Drug Delivery through Co-amorphous Solid Dispersions: A Comprehensive and Updated Review on Physicochemical Characteristics and Biological Potential.通过共无定形固体分散体进行药物递送:关于物理化学特性和生物学潜力的全面且最新的综述
Recent Adv Drug Deliv Formul. 2025 Apr 18. doi: 10.2174/0126673878351727250409094214.
7
Recent Advances in Understanding the Micro- and Nanoscale Phenomena of Amorphous Solid Dispersions.理解无定形固体分散体的微观和纳米现象的最新进展。
Mol Pharm. 2019 Oct 7;16(10):4089-4103. doi: 10.1021/acs.molpharmaceut.9b00601. Epub 2019 Sep 5.
8
Amorphous Solid Dispersion as Drug Delivery Vehicles in Cancer.无定形固体分散体作为癌症治疗中的药物递送载体
Polymers (Basel). 2023 Aug 11;15(16):3380. doi: 10.3390/polym15163380.
9
Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.曲尼司特无定形固体分散体的理化性质和药代动力学特征研究:提高了在胃液中的溶解度和口服生物利用度。
Drug Metab Pharmacokinet. 2012;27(4):379-87. doi: 10.2133/dmpk.dmpk-11-rg-101. Epub 2012 Jan 13.
10
Ternary Solid Dispersions: A Review of the Preparation, Characterization, Mechanism of Drug Release, and Physical Stability.三元固体分散体:制备、表征、药物释放机制及物理稳定性综述
Pharmaceutics. 2023 Aug 10;15(8):2116. doi: 10.3390/pharmaceutics15082116.

本文引用的文献

1
Preliminary investigation on the mechanism of anti-periodontitis effect of based on bioinformatics analysis and verification.基于生物信息学分析和实验验证对[具体药物或物质]抗牙周炎作用机制的初步研究 。 需注意,原文中“based on bioinformatics analysis and verification”里第二个“and”后面似乎缺失了具体内容。
Heliyon. 2024 Aug 3;10(16):e35744. doi: 10.1016/j.heliyon.2024.e35744. eCollection 2024 Aug 30.
2
Development of raft-forming liquid formulations loaded with ginger extract-solid dispersion for treatment of gastric ulceration.用于治疗胃溃疡的载姜提取物-固体分散体的筏状形成液体制剂的研发。
Heliyon. 2024 May 23;10(11):e31803. doi: 10.1016/j.heliyon.2024.e31803. eCollection 2024 Jun 15.
3
Ethnomedicinal values of L. as a panacea against multiple human ailments: a state of art review.
作为治疗多种人类疾病的万灵药,L. 的民族药用价值:一篇综述。
Front Chem. 2023 Nov 14;11:1297300. doi: 10.3389/fchem.2023.1297300. eCollection 2023.
4
A comprehensive review of medicinal Toxicodendron (Anacardiaceae): Botany, traditional uses, phytochemistry and pharmacology.漆树(漆树科)药用植物的全面综述:植物学、传统用途、植物化学和药理学。
J Ethnopharmacol. 2024 Jan 10;318(Pt A):116829. doi: 10.1016/j.jep.2023.116829. Epub 2023 Jul 8.
5
Quality by design-based development and optimization of fourth-generation ternary solid dispersion of standardized Piper longum extract for melanoma therapy.基于质量源于设计的第四代三元固态分散体的开发和优化,用于治疗黑色素瘤的标准化荜茇提取物。
Drug Deliv Transl Res. 2023 Dec;13(12):3094-3131. doi: 10.1007/s13346-023-01375-y. Epub 2023 Jun 9.
6
Antioxidant Activity in Extracts from Family: Cardamom, Turmeric, and Ginger.姜科植物提取物的抗氧化活性:小豆蔻、姜黄和生姜。
Molecules. 2023 May 11;28(10):4024. doi: 10.3390/molecules28104024.
7
The Potential of as a Source of Biologically Active Compounds-A Review of the Recent Literature and Patents.作为生物活性化合物来源的潜力——对近期文献和专利的综述。
Molecules. 2023 May 9;28(10):3993. doi: 10.3390/molecules28103993.
8
L.: Phenolic Compounds Composition and Biological Activity of Commercial Samples and Its Aqueous and Hydromethanolic Extracts.L.:市售样品及其水提取物和氢甲醇提取物中的酚类化合物组成和生物活性。
Antioxidants (Basel). 2023 Feb 22;12(3):550. doi: 10.3390/antiox12030550.
9
Absorption, metabolism, bioactivity, and biotransformation of epigallocatechin gallate.没食子酸表没食子儿茶素酯的吸收、代谢、生物活性和生物转化。
Crit Rev Food Sci Nutr. 2024;64(19):6546-6566. doi: 10.1080/10408398.2023.2170972. Epub 2023 Feb 2.
10
Preparation of Solid Dispersion of Polygonum Cuspidatum Extract by Hot Melt Extrusion to Enhance Oral Bioavailability of Resveratrol.采用热熔挤出法制备虎杖提取物固体分散体以提高白藜芦醇的口服生物利用度。
Molecules. 2023 Jan 11;28(2):737. doi: 10.3390/molecules28020737.